SCHEMBL6633941

SCHEMBL6633941

CCC1CCCCC12C(=O)C2=O

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8621959 0.82 MAPK1 (0.33) TDP1GAAHPGDMAPK1
SCHEMBL6557170 0.69 GAA (0.32) GAA
SCHEMBL1836217 0.68
SCHEMBL13940176 0.67 TDP1 (0.66) TDP1GAAHPGDMAPK1
SCHEMBL2058604 0.67
SCHEMBL21295509 0.67
SCHEMBL538213 0.67
SCHEMBL22179394 0.67 ABCB11 (0.30)
SCHEMBL15658241 0.67 MEN1 (0.31)
SCHEMBL1973593 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1472252-A1 SUBSTITUTED FUSED PYRAZOLECARBOXYLIC ACID ARYLAMIDES AND RELATED COMPOUNDS Neurogen Corporation (US) 2004-11-03 EP disclosed
WO-2003066634-A1 SUBSTITUTED FUSED PYRAZOLECARBOXYLIC ACID ARYLAMIDES AND RELATED COMPOUNDS NEUROGEN CORPORATION (US) 2003-08-14 WO disclosed
EP-1315703-A1 ARYL SUBSTITUTED TETRAHYDROINDAZOLES AND THEIR USE AS LIGANDS FOR THE GABA-A RECEPTOR NEUROGEN CORPORATION (US) 2003-06-04 EP disclosed
WO-2002020492-A1 ARYL SUBSTITUTED TETRAHYDROINDAZOLES AND THEIR USE AS LIGANDS FOR THE GABA-A RECEPTOR NEUROGEN CORPORATION (US) 2002-03-14 WO disclosed